Tacroximes: novel unique compounds for the recovery of organophosphorus-inhibited acetylcholinesterase

Future Med Chem. 2019 Oct;11(20):2625-2634. doi: 10.4155/fmc-2019-0027. Epub 2019 Sep 26.

Abstract

Aim: Organophosphorus compounds are irreversible inhibitors of AChE. Without immediate countermeasure, intoxication leads quickly to death. None of the clinically-used causal antidotes can ensure a good prognosis for any poisoned patient. When fallen into the wrong hands, organophosphates represent a serious threat to mankind. Results & methodology: Herein, we describe two novel compounds as unique merged molecules built on a tacrine scaffold against organophosphorus intoxication. These reactivators of AChE have balanced physicochemical properties, and should be able to cross the blood-brain barrier with a slightly lowered cytotoxicity profile compared to reference tacrine. Conclusion: Their efficiency compared with pralidoxime and obidoxime was proved against dichlorvos.

Keywords: acetylcholinesterase; dichlorvos; nerve agent; organophosphorus; oxime reactivator; pesticide; tacrine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacology*
  • Organophosphorus Compounds / chemistry
  • Organophosphorus Compounds / toxicity*
  • Oximes / chemistry
  • Oximes / pharmacology*
  • Structure-Activity Relationship

Substances

  • Cholinesterase Inhibitors
  • Organophosphorus Compounds
  • Oximes